TheStreet.com Network: MainStreet.com | StockPickr.com | BankingMyWay.com | Geezeo.com | RealMoney | Nails on the Numbers(NEW) | Dividend.com
TheStreet.com
ACCESS REALMONEY
ADVISORS NOW!
Subscribe to Expert Advisors
Free Newsletters
  • Headlines
  • Business News
  • TheStreet Picks
  • Video
  • Investing A-to-Z
  • Life & Money
  • Portfolio & Tools
  • RealMoney
  • $ Services
  • Cramer's Action Alerts PLUS
  • Biotech Select(NEW)
  • Breakout Stocks
  • Daily Swing Trade
  • Dividend Stock Advisor
  • ETF Shark Alerts
  • InsiderInsights
  • Nails On The Numbers(NEW)
  • Options Alerts
  • Ratings Services
  • RealMoney
  • RealMoney Silver
  • Stocks Under $10
  • Telecom Connection
  • Top Stocks
  • Value Investor
  • Action Alerts PLUS - $50 off
  • Portfolio
  • Calculators
  • Stockpickr
  • Stockpickr Answers
  • Geezeo Confessions
  • Mad Money Performance
  • Stock Screener
  • Mutual Fund Screener
  • ETF Screener
  • Banks & Thrifts Screener
  • Insurers & HMOs Screener
  • Glossary
  • Horo$copes
pjava09.thestreet.com

Mergers & Acquisitions

« Back
Page 2 of 11
Next »
Article

ImClone Soars on Buyout Bid (Update2)

By Elizabeth Trotta

ImClone says it's 'studying the situation' after receiving a $60-per-share bid from Bristol-Myers.

Related Topics: Drugs | Health Care | Biotech | M&A

05:57PM 07/31/08

Article

ImClone Soars on Buyout Bid (Update)

By Elizabeth Trotta

The stock soars well above the $60 that Bristol-Myers is offering.

Related Topics: M&A | Biotech | Drugs | Health Care

03:09PM 07/31/08

Article

Biotech Stocks Burn Higher on M&A Fire

By Adam Feuerstein

The sector is trading higher on today's buyout bid. One analyst offers a list of who else could tie the knot in the drug and biotech space.

Related Topics: Biotech | M&A | Drugs | Health Care

12:44PM 07/31/08

Article

Bristol-Myers Offers $60/Share for ImClone

By TSC Staff

ImClone shares are soaring on news of the $4.5 billion cash bid.

Related Topics: M&A | Biotech | Drugs | Health Care

08:59PM 07/30/08

Article

What Now, Genentech Investors?

By Adam Feuerstein

Minority shareholders will have to reinvest their $44 billion somewhere after the buyout. What about a spinoff?

Related Topics: Drugs | Biotech | M&A | Health Care

06:59AM 07/23/08

Article

Roche Bids for Rest of Genentech (Update)

By Elizabeth Trotta

The offer is worth nearly $44 billion and is valued at $89 a share.

Related Topics: Health Care | Drugs | M&A | Biotech

12:04PM 07/21/08

Article

Yahoo! Holder to Vote Company Slate

By Pia Sarkar

Legg Mason aims to keep the current board in place.

Related Topics: Internet | M&A | Technology

11:41AM 07/18/08

Article

Merrill to Sell Bloomberg Stake: Report

By TSC Staff

The investment bank could reap up to $5 billion by selling its interest back to the financial information firm.

Related Topics: Earnings | M&A | Banks | Financial Services

05:09PM 07/16/08

Article

ViroPharma to Buy Lev Pharma

By Adam Feuerstein

ViroPharma will pay $2.75 a share in cash and stock for the development-stage biotech.

Related Topics: Drugs | Health Care | Biotech | M&A

11:07AM 07/15/08

Article

Yahoo! Slides on Latest Microsoft Stiff-Arm

By Pia Sarkar

Once again, the company rejects a deal for its search operations.

Related Topics: Technology | M&A | Internet

01:10PM 07/14/08

Article

Citi Sells German Bank for $7.7 Billion

By TSC Staff

The struggling banking giant has been shedding assets as part of CEO Vikram Pandit's retooling.

Related Topics: Financial Services | Banks | M&A

12:29PM 07/11/08

Article

Yahoo! Tweaks Search Tools

By Pia Sarkar

But the company has bigger fish to fry, some would say.

Related Topics: Technology | Internet | M&A

01:17PM 07/10/08

Article

IndyMac Sells Retail Mortgage Branches

By TSC Staff

The lender attempts to address liquidity concerns raised by the Office of Thrift Supervision.

Related Topics: M&A | Banks | Financial Services

06:49PM 07/08/08

Article

Icahn, Microsoft Revive Hope for Yahoo! Deal

By Pia Sarkar

With the activist investor pressing his case, Microsoft says it would be open to talks with a new Yahoo! board. Shares of the Internet portal are soaring nearly 11%.

Related Topics: Technology | M&A | Internet

05:26PM 07/07/08

Article

Microsoft Move Puts Heat on Yahoo!

By Pia Sarkar

The software giant makes another play to get a piece -- or all -- of the Internet company.

Related Topics: Technology | Internet | M&A

04:24PM 07/07/08

« Back
Page 2 of 11
Next »
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Sign up for our FREE newsletters now. See All

  • Cramer's Daily Booyah!
  • Before the Bell
Submit Privacy Policy

Most Recent RealMoney Headlines

  1. Fannie-Freddie Plan Would Be Big for Banks
  2. Editors' Picks: RealMoney Stories of the Week
  3. Nice Bounce, But Little Has Changed

Premium Stock Ideas

THE INSIDE INFORMATION HE GETS, YOU GET.

Unbiased. Uncensored. That's how insider Adam Feuerstein gives you his take on what's hot and what's not in biotech. You'll get the top picks on his subscriber-only Recommended List — stocks he believes, only after extensive research, have the potential for outsized returns even in this risky sector.

$150 Charter Savings

THE INSIDE INFORMATION HE GETS, YOU GET.
Find more premium investing ideas
Financial Tools

Financial Glossary

Enhance your investing education as you read articles on TheStreet.com. Look for the symbol throughout our site to look up items. Browse Glossary

Check a Rating

How does your portfolio rate? Enter a ticker below or go straight to our screeners: Stocks| ETFs| Funds

Sponsored by:

Premium Services

Action Alerts PLUS | Stocks Under $10 | RealMoney | Options Alerts | Breakout Stocks | Top Stocks | VIEW ALL

Get Cramer's portfolio stock picks at Action Alerts PLUS — take $50 off
Find Dykstra's DITM calls only here — save $100 on Nails on the Numbers
FREE 30-page RealMoney investing report by Dan Fitzpatrick of "3 Stocks I Saw on TV"
Profit from legal insider trading — start with $50 off Insider Insights
View Directory
Jim Cramer's Action Alerts PLUS RealMoney RealMoney Silver Biotech Select(NEW) Stocks Under $10 Top Stocks Nails on the Numbers(NEW)

Resources
  • About Us
  • Advertise
  • Corrections
  • Customer Service
  • Employment
  • Investor Relations
  • Log In
  • Privacy Policy
  • Readers' Feedback
  • Sitemap
  • Subscribe
  • Terms of Use
TheStreet Premium Services
Cramer's Action Alerts PLUS:  Inside his portfolio
More Info | Free Trial | Subscribe | Login
Biotech Select:  Insider picks what's hot in biotech
More Info | Free Trial | Subscribe | Login
Breakout Stocks:  Get in before they're hot
More Info | Free Trial | Subscribe | Login
Daily Swing Trade:  Play on market moves
More Info | Free Trial | Subscribe | Login
Dividend Stock Advisor:  Stable income investing
More Info | Free Trial | Subscribe | Login
ETF Shark Alerts:  Winning opportunities
More Info | Free Trial | Subscribe | Login
InsiderInsights:  Picks based on insider trading data
More Info | Free Trial | Subscribe | Login
Nails on the Numbers:  Dykstra's DITM calls
More Info | Free Trial | Subscribe | Login
Options Alerts:  Let volatility work for you
More Info | Free Trial | Subscribe | Login
RealMoney:  Pros' ideas & strategies
More Info | Free Trial | Subscribe | Login
RealMoney Silver:  5 key investor services
More Info | Free Trial | Subscribe | Login
Stocks Under $10:  Low price/high potential
More Info | Free Trial | Subscribe | Login
Telecom Connection:  Essential investing info
More Info | Free Trial | Subscribe | Login
Top Stocks:  Masterful market charts
More Info | Free Trial | Subscribe | Login
Value Investor:  Top undervalued stocks
More Info | Free Trial | Subscribe | Login
Ratings Services:  Data you can bank on
More Info | Unlimited Reports
Free Newsletters
See All Free Newsletters

After the Bell

Before the Bell

Booyah! Newsletter

ETF Weekly

Midday Bell

TSC Top Ten Stories Newsletter

University Newsletter

Winners & Losers

Privacy Policy
Podcasts
Daily RSS Updates

TheStreet Mobile Edition

Take Our Tour